FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutics and medicine and concerns a pharmaceutical composition for treating and preventing preexcitation syndrome (WPW-syndrome) containing 9-diethylaminoethyl-2-tert-butyl-imidazo[1,2-a] benzimidazole dihydrochloride of formula I as an agent.
EFFECT: composition shows high efficacy.
6 cl, 6 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PATIENTS FOR PAROXYSMAL RECIPROCAL TACHICARDIA ON THE BACKGROUND OF WPW SYNDROME | 1999 |
|
RU2195983C2 |
METHOD FOR CHOOSING ANTIARRHYTHMIC THERAPY FOR ATRIOVENTRICULAR TACHYCARDIA | 0 |
|
SU1806741A1 |
METHOD OF DIAGNOSING LEFT-SIDED LOCALISATION OF ADDITIONAL ATRIOVENTRICULAR CONNECTIONS IN CHILDREN WITH WOLFF-PARKINSON-WHITE SYNDROME | 2011 |
|
RU2471410C1 |
DRUG PREPARATION FOR TREATING CARDIAC ARRHYTHMIA | 2013 |
|
RU2513580C1 |
AGENT POSSESSING ANTIARRHYTHMIC, ANTIFIBRILLATORY, ANTI-ISCHEMIC ACTION, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2477130C1 |
METHOD FOR INTRAOPERATIVE TOPICAL DIAGNOSIS OF ATRIOVENTRICULAR ADDITIONAL CONDUCTION PATH IN WOLFF-PARKINSON-WHITE SYNDROME | 0 |
|
SU1801368A1 |
METHOD FOR SELECTING OPTIMAL VARIANT OF TREATMENT BY ANTIARRHYTHMIC AGENTS | 0 |
|
SU1681241A1 |
METHOD FOR PHARMACOLOGICAL AUTONOMIC HEART BLOCK | 2014 |
|
RU2572339C1 |
METHOD FOR TREATMENT OF SUPRAVENTRICULAR TACHYCARDIA | 0 |
|
SU1676599A1 |
METHOD OF ADDITIONAL CONDUCTING TRACTS MAPPING | 2006 |
|
RU2354421C2 |
Authors
Dates
2012-06-20—Published
2011-02-01—Filed